Infection in ECMO patients: Changes in epidemiology, diagnosis and prevention

Anaesth Crit Care Pain Med. 2024 Feb;43(1):101319. doi: 10.1016/j.accpm.2023.101319. Epub 2023 Nov 2.

Abstract

Patients with prolonged duration of extracorporeal membrane oxygenation support (ECMO) are a vulnerable population for sepsis, particularly ventilator-associated pneumonia and bloodstream infections. Rates differ between venous-arterial and venous-venous ECMO patients and according to the cannulation technique used. The presence of particular organisms depends on local epidemiology, antibiotic exposure, and the duration of the intervention; patients undergoing ECMO for more than three weeks present a high risk of persistent candidemia. Recognizing predisposing factors, and establishing the best preventive interventions and therapeutic choices are critical to optimizing the management of these complications. Infection control practices, including shortening the period of the indwelling devices, and reducing antibiotic exposure, must be followed meticulously. Innovations in oxygenator membranes require an updated approach. Hand hygiene and avoiding breaking the circuit-oxygenator sterility are cornerstones. ECMO management would benefit from clearer definitions, optimization of infection control strategies, and updated infectious clinical practice guidelines.

Keywords: Antimicrobial stewardship; Bloodstream infections; Extracorporeal Life Support Organization (ELSO); Extracorporeal membrane oxygenation (ECMO); Nosocomial infections; Ventilator-associated pneumonia (VAP).

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Extracorporeal Membrane Oxygenation* / methods
  • Humans
  • Infection Control
  • Retrospective Studies
  • Risk Factors
  • Sepsis*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents